Reunite™ reconstitution made simple

An easy-to-use, dual-chamber cartridge autoinjector featuring SHL Medical’s Needle Isolation Technology (NIT®), designed to support the automated reconstitution and delivery of lyophilized formulations.

Let's connect

Looking for an autoinjector for your lyophilized formulations?

Get in touch Download specs

What makes Reunite™ autoinjector unique

Automated reconstitution

Reunite supports automated reconstitution and delivery of lyophilized drugs, replacing numerous and complicated user steps for manual reconstitution vial kits.

NIT®

Reunite is built with Needle Isolation Technology (NIT®), which provides complete control of cannula gauge and length to support target injection time and injection depth.

[.png] Reunite NIT-Mix HAND1757-4164x4164-0e0d1de

Ease-of-use

Reunite features a simple three-step process, ensuring accurate dosing with a user-friendly design for safe and effortless use.

Watch to learn about Reunite's three-step process: unlock, twist, push

[.jpg] meet-reunite-dual-chamber-cartridge-autoinjector-lyophilized-drugs

From 10+ Steps to 3

Traditional vial kits for lyophilized drugs involve multiple components and more than ten steps, including disinfecting vials, attaching needles, transferring diluent, mixing, and preparing for injection. Each step adds time, complexity, and risk of dosing errors or contamination.

Reunite™ simplifies this to just three steps: unlock, twist, push. This streamlined approach improves safety, consistency, and ease of use for patients.

Unlock to Reconstitute

Unlock the knob to initiate automated reconstitution.

Twist off Cap

Twist off the needle cap.
The pre-attached needle (NIT®) moves backward to pierce the cartridge septum, open the fluid path and initiate priming.

Push to Inject

Push the device against the injection site to begin the injection. You will hear a start click. The injection is complete when the plunger rod stops moving.

Market-proven technology

NIT® is an integrated, pre-attached needle technology for cartridge-based injections. NIT® allows users to simply unlock the cap to open the fluid path. The needle cover automatically extends and the autoinjector automatically primes.

The first NIT®-enabled autoinjector was launched in 2018 for a metabolic treatment. In 2024 and 2025, the latest NIT-enabled autoinjector was launched in the US and Europe, respectively, for the treatment of two dermatological conditions.

[.gif] Reunite-NIT cannula ending-4k-20250915

More than 25 years of engineering excellence

Reunite™ is the culmination of 25 years of engineering excellence. The best-in-class user experience is achieved by integrating and hiding the needle and automating all critical user steps, reducing the burden and risk of manual mixing and dosing and making lyophilized drug delivery as simple as a standard autoinjector.